These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 22728661)
1. Effects of dopamine and serotonin antagonist injections into the striatopallidal complex of asymptomatic MPTP-treated monkeys. Neumane S; Mounayar S; Jan C; Epinat J; Ballanger B; Costes N; Féger J; Thobois S; François C; Sgambato-Faure V; Tremblay L Neurobiol Dis; 2012 Oct; 48(1):27-39. PubMed ID: 22728661 [TBL] [Abstract][Full Text] [Related]
2. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Mounayar S; Boulet S; Tandé D; Jan C; Pessiglione M; Hirsch EC; Féger J; Savasta M; François C; Tremblay L Brain; 2007 Nov; 130(Pt 11):2898-914. PubMed ID: 17855373 [TBL] [Abstract][Full Text] [Related]
3. Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Grabli D; McCairn K; Hirsch EC; Agid Y; Féger J; François C; Tremblay L Brain; 2004 Sep; 127(Pt 9):2039-54. PubMed ID: 15292053 [TBL] [Abstract][Full Text] [Related]
4. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys. Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922 [TBL] [Abstract][Full Text] [Related]
5. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor. Carlson BB; Wisniecki A; Salamone JD Psychopharmacology (Berl); 2003 Jan; 165(3):229-37. PubMed ID: 12420151 [TBL] [Abstract][Full Text] [Related]
6. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034 [TBL] [Abstract][Full Text] [Related]
7. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains. Haobam R; Sindhu KM; Chandra G; Mohanakumar KP Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeys. Bezard E; Ravenscroft P; Gross CE; Crossman AR; Brotchie JM Neurobiol Dis; 2001 Apr; 8(2):343-50. PubMed ID: 11300729 [TBL] [Abstract][Full Text] [Related]
9. Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study. François C; Grabli D; McCairn K; Jan C; Karachi C; Hirsch EC; Féger J; Tremblay L Brain; 2004 Sep; 127(Pt 9):2055-70. PubMed ID: 15292054 [TBL] [Abstract][Full Text] [Related]
10. Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis. Boulet S; Mounayar S; Poupard A; Bertrand A; Jan C; Pessiglione M; Hirsch EC; Feuerstein C; François C; Féger J; Savasta M; Tremblay L J Neurosci; 2008 Sep; 28(38):9575-84. PubMed ID: 18799689 [TBL] [Abstract][Full Text] [Related]
11. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Pifl C; Hornykiewicz O Neurochem Int; 2006 Oct; 49(5):519-24. PubMed ID: 16698121 [TBL] [Abstract][Full Text] [Related]
13. Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys. Gagnon D; Eid L; Coudé D; Whissel C; Di Paolo T; Parent A; Parent M Front Neuroanat; 2018; 12():38. PubMed ID: 29867377 [TBL] [Abstract][Full Text] [Related]
14. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337 [TBL] [Abstract][Full Text] [Related]
15. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism. Anderson DW; Bradbury KA; Schneider JS Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732 [TBL] [Abstract][Full Text] [Related]
16. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys. Rioux L; Frohna PA; Joyce JN; Schneider JS Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972 [TBL] [Abstract][Full Text] [Related]
17. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice. Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184 [TBL] [Abstract][Full Text] [Related]
19. Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Worbe Y; Baup N; Grabli D; Chaigneau M; Mounayar S; McCairn K; Féger J; Tremblay L Cereb Cortex; 2009 Aug; 19(8):1844-56. PubMed ID: 19068490 [TBL] [Abstract][Full Text] [Related]
20. Sensitivity to the motoric effects of a dopamine receptor antagonist differs as a function of age at the time of dopamine depletion. Sandstrom MI; Bruno JP Dev Psychobiol; 1997 May; 30(4):293-300. PubMed ID: 9142505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]